Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 46 results for "dr khorana"

Nobel Laureate to visit Chandigarh on January 5
New Delhi Pioneer

Nobel Laureate to visit Chandigarh on January 5

aureate Professor Venkatraman Ramakrishnan would visit Panjab University and deliver INST-PSCST Hargobind Khorana & DST Inspire Inaugural Lecture at University Law Auditorium on January 5. PU Vice Chancellor Arun K Grover, Director, INST Ashok K ... New Delhi Pioneer, 1 month ago

Discussion with Dr. Alok Khorana on thro...

Loading........ 468 views Description: This is my conversation with Dr. Alok Khorana, Director of the GI Malignancy Program at the Cleveland Clinic. Dr. Khorana will be presenting an abstract Saturday, May 30, 2015 at the ASCO Annual ...
 Oncology Tube1 month ago

Reply to S. Alanee and D. Dynda [CORRESPONDENCE]

Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN Corresponding author: Lois B. Travis, MD, ScD, Cancer Survivorship Research Program, Indiana University Melvin and Bren Simon Cancer Center, 535 Barnhill Dr RT433, ...
 Journal of Clinical Oncology1 day ago
CBS News

At-Home Colon Cancer Screening Test can be Effective, Study Says

The effectiveness rate of using the FIT during the first year was 84.5 percent. (Photo : Wiki Commons) There might be an effective alternative to undergoing a colonoscopy. According to a new study carried out by researchers at Kaiser Permanente ...
 Counsel & Heal2 weeks ago CBS Health: Study: At-home test for colon cancer a good alternative  CBS News2 weeks ago At-home colon cancer screening found accurate in study  UPI2 weeks ago
Hindustan Times

Nobel laureate calls astrology and homoeopathy useless

OLD TRADITIONS CHALLENGED January 14, 2016 8:16 pm [embedded content] Tweet by BHARTESH SINGH THAKUR, HINDUSTAN TIMES, NEW DELHI (TNS) INDIAN-BORN Nobel laureate Venkatraman Ramakrishnan dismissed as baseless last year's claims at the ...
 Manila Times3 weeks ago Nobel laureate calls astrology, homoeopathy useless  Hindustan Times1 month ago

'Some famous scientists did not nurture talent'

Chandigarh: Venkatraman Ramakrishnan, the renowned Indian-American scientist whose pathbreaking work in molecular biology won him the 2009 Nobel Prize in chemistry, has said some of the famous Indian scientists did not nurture equally famous people ...
 Times of India1 month ago

"If You Prick Us, Do We Not Bleed?" Whom Should We Choose? [CORRESPONDENCE]

2016 by American Society of Clinical Oncology ⇑ , Angela Lamarca , Richard A. Hubner and Juan W. Valle The Christie NHS Foundation Trust, Manchester, United Kingdom Corresponding author: Dr Mairéad G. McNamara, MB, PhD, University of ...
 Journal of Clinical Oncology1 month ago

University of Jhang to be set up soon

There are no public universities in the district. PHOTO: FILE FAISALABAD: The project digest (PC-1) of the University of Jhang has been prepared and the Higher Education Department has been asked to recruit administrative and academic staff. ...
 The Express Tribune1 month ago

GCU turns 152

LAHORE: The Government College University (GCU) Lahore, the oldest seat of learning in Pakistan, turns 152 today (Friday). Started in the Haveli of Dhian Singh in the walled city on Jan 1, 1864. The college was initially affiliated with the ...
 Daily Times1 month ago
Medical News Today

First Data Unveiled from CALLISTO Program Examining the Use of XARELTO ® (rivaroxaban) for Treating Blood Clots in People with Cancer

First of Nine Studies, Examining the Ability of Rivaroxaban to Reduce theBurden of Cancer-Associated Blood Clots, Presented at ASH Annual Meeting ORLANDO, FL (December 7, 2015) — Janssen Pharmaceuticals, Inc. (Janssen) and its development ...
 PressReleasePoint1 month ago New data finds benefit of rivaroxaban treatment in patients with blood clots and cancer 8 Dec 2015  Medical News Today2 months ago Janssen Pharmaceuticals, Inc. Release: First Data Unveiled From CALLISTO Program Examining The Use Of XARELTO (rivaroxaban) For Treating Blood Clots In People With Cancer  BioSpace2 months ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less